Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)

TerminatedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Thrombocytopenia
Trial Locations (21)

15213

University of Pittsburgh, Pittsburgh

19104

University of Pennsylvania, Philadelphia

21201

University of Maryland, Baltimore

21205

Johns Hopkins Hospital, Baltimore

27599

University of North Carolina, Chapel Hill

27710

Duke University, Durham

30322

Emory University, Atlanta

44106

Case Western Reserve University, Cleveland

52242

University of Iowa, Iowa City

53215

St. Luke's Medical Center, Milwaukee

53226

Froedtert Memorial Lutheran Hospital, Milwaukee

53792

University of Wisconsin, Madison, Madison

54601

Gunderson Lutheran Clinic, La Crosse

55455

University of Minnesota, Minneapolis

70112

Tulane University, New Orleans

75390

University of Texas Southwestern Medical Center, Dallas

98104

University of Washington, Seattle

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

Children's Hospital Boston, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Carelon Research

OTHER

NCT00594685 - Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study) | Biotech Hunter | Biotech Hunter